Erlotinib Hydrochloride from Canada
Erlotinib hydrochloride is an epidermal growth factor receptor (EGFR) inhibitor used in non-small cell lung cancer treatment. As a quinazoline derivative (aromatic heterocycle with nitrogen), it qualifies under HTS 2933.99.75.00 for aromatic heterocyclic drugs.
Duty Rate — Canada → United States
16.5%
Rate breakdown
9903.05.2910%Section 301 (forced labor) — additional 10% ad valorem on products of Canada
Import Tips
• Include FDA IND/ANDA documentation and stability data for API import
• Verify polymorphic form and particle size specifications match DMF
• Label shipments clearly as 'Bulk Drug Substance - Rx Only' to prevent retail misclassification